These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12707410)

  • 21. Getting at the heart of quality and economics.
    Neumann ME
    Nephrol News Issues; 2007 Mar; 21(4):42. PubMed ID: 17393927
    [No Abstract]   [Full Text] [Related]  

  • 22. Health indicators for renal replacement therapy in Saudi Arabia.
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):183-9. PubMed ID: 26950962
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of industry on renal guideline development.
    Coyne DW
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):3-7; discussion 13-4. PubMed ID: 17699377
    [No Abstract]   [Full Text] [Related]  

  • 24. A plan for improving outcomes for patients with chronic renal failure.
    White JD
    Nephrol News Issues; 1997 Apr; 11(4):26-7. PubMed ID: 9287686
    [No Abstract]   [Full Text] [Related]  

  • 25. Chapter 11 Clinical, haematological and biochemical parameters in patients receiving renal replacement therapy in paediatric centres in the UK in 2010: national and centre-specific analyses.
    Pruthi R; Maxwell H; Casula A; Tse Y; Sinha MD; O'Brien C; Lewis M; Inward C
    Nephron Clin Pract; 2012; 120 Suppl 1():c219-32. PubMed ID: 22964569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guideline-based medical quality management in dialysis. Motivation and structuring of a quality-management system and integration of earlier disease stages of chronic renal failure].
    Stoffel MP; Lauterbach KW; Baldamus CA
    Z Arztl Fortbild Qualitatssich; 2004 Oct; 98(7):609-16. PubMed ID: 15595603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dilemma of making recommendations based on weak evidence.
    Zoccali C; Seck S
    Semin Dial; 2011; 24(1):27-9. PubMed ID: 21338389
    [No Abstract]   [Full Text] [Related]  

  • 28. Sustainability and equity of renal replacement therapy in Spain.
    de Francisco AL
    Nefrologia; 2011; 31(3):241-6. PubMed ID: 21629331
    [No Abstract]   [Full Text] [Related]  

  • 29. Attempting to build solid recommendations on a shaky evidence base.
    Johnson DW
    Semin Dial; 2011; 24(1):22-4. PubMed ID: 21338387
    [No Abstract]   [Full Text] [Related]  

  • 30. Evolution of nephrology and renal replacement therapy.
    Bonomini V
    Int J Artif Organs; 1993 Oct; 16(10):685-7. PubMed ID: 8125612
    [No Abstract]   [Full Text] [Related]  

  • 31. End stage renal disease and renal replacement therapy--challenges and future prospective in Nepal.
    Hada R
    JNMA J Nepal Med Assoc; 2009; 48(176):344-8. PubMed ID: 21105565
    [No Abstract]   [Full Text] [Related]  

  • 32. Clash of cultures: nephrologists meet the market economy.
    Bennett WM
    Nephrol Dial Transplant; 2000 Nov; 15(11):1749-50. PubMed ID: 11071959
    [No Abstract]   [Full Text] [Related]  

  • 33. QA assessment, infection control, ethical issues highlight CA dialysis meeting.
    Neumann ME
    Nephrol News Issues; 1994 Jun; 8(6):29, 33. PubMed ID: 8008088
    [No Abstract]   [Full Text] [Related]  

  • 34. Improving quality of care and social work outcomes in dialysis.
    Callahan MB; Witten B; Johnstone S
    Nephrol News Issues; 1997 Feb; 11(2):40-3. PubMed ID: 9096465
    [No Abstract]   [Full Text] [Related]  

  • 35. Working toward changes in nephrology practice.
    Parker T; Johnson D; Nissenson A
    Nephrol News Issues; 2014 Mar; 28(3):16. PubMed ID: 24720009
    [No Abstract]   [Full Text] [Related]  

  • 36. Leading Integrated Kidney Care Entities of the Future.
    Johnson DS; Meyer KB
    Adv Chronic Kidney Dis; 2018 Nov; 25(6):523-529. PubMed ID: 30527553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QUality European STudies (QUEST)--a step forward in the quality of RRT care.
    Jager KJ; Zoccali C
    Nephrol Dial Transplant; 2005 Sep; 20(9):2005-6. PubMed ID: 16091380
    [No Abstract]   [Full Text] [Related]  

  • 38. Future developments in renal care, the patient's perspective.
    Erben K
    EDTNA ERCA J; 1999; 25(1):9-11. PubMed ID: 10418369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of chronic renal failure. Family practitioner and nephrologist hand in hand].
    Stiefelhagen P
    MMW Fortschr Med; 2015 Feb; 157(2):18-9. PubMed ID: 25743503
    [No Abstract]   [Full Text] [Related]  

  • 40. RPA's strategy to enhance and improve continuous quality improvement in the ESRD program. Part 2 of 2. Renal Physicians Association.
    Clin Nephrol; 2000 Dec; 54(6):501-2. PubMed ID: 11140813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.